Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
64,036.43 -465.14 (-0.72%) CMC Crypto 200
1,371.97 +59.34 (+4.52%)
Organigram Holdings Inc. (OGI.TO)
| Previous close | 2.5900 |
| Open | 2.6400 |
| Bid | 2.5900 x N/A |
| Ask | 2.6100 x N/A |
| Day's range | 2.5550 - 2.6900 |
| 52-week range | 1.3500 - 3.9500 |
| Volume | |
| Avg. volume | 447,809 |
| Market cap | 268.827M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.5100 |
| Earnings date | 11 Jul 2024 - 15 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.86 |
Business WireOrganigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
TORONTO, April 08, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender diversity. Fifty percent of the Company’s executive leadership team, including its CEO, are women.
Business WireOrganigram’s Popular SHRED Brand Surpasses $200 Million in Yearly Retail Sales
TORONTO, April 03, 2024--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, celebrates a monumental achievement as its SHRED brand surpasses the $200 million mark in yearly retail sales.1
Business WireOrganigram Successfully Closes Previously Announced Underwritten Public Offering
TORONTO, April 02, 2024--Organigram Holdings Inc. ("Organigram" or the "Company") (TSX: OGI; NASDAQ: OGI) announces today the closing of its previously announced underwritten public offering of units of the Company (the "Units") for total gross proceeds of C$28,750,230 (the "Offering"). The Company sold 8,901,000 Units at a price of C$3.23 per Unit, which included 1,161,000 Units sold pursuant to the exercise in full of the Underwriters’ over-allotment option.
